There are many things Indianapolis is known for around the world. For many, the first that comes to mind is the Indy 500 at the Indianapolis Motor Speedway. Another spotlight shines on the thriving, robust life sciences sector that provides medical innovations to people all over the globe such as COVID-19 tests and vaccines, cardiology devices, insulin, and more.
What’s not so familiar is the intersection of racing and life sciences. Watch this FrameWORX where we kicked off the month of May in Indy with IMS. We talked about the impact IMS has had in most recent years around the health and well-being of Hoosiers both on and off the track. From the innovative safety measures for drivers to keeping fans safe at the track to the more recent race to deliver more than 100,000 COVID vaccines to Hoosiers during the pandemic, IMS has created more than a legacy in racing, it’s a legacy of innovation.
In this session you’ll hear from:
- J. Doug Boles, president of Indianapolis Motor Speedway
- Tim Baughman, director of Track Safety for IndyCar
- Julia Vaizer, MD, Director of Medical Services for IMS and Assistant Professor, Clinical Emergency Medicine at IU Health
- Patty Martin, president and CEO of BioCrossroads